With India in the throes of an outbreak of Chikungunya, local drugmaker Zydus Cadila has stepped up to develop a vaccine against the crippling viral disease--…
Novo Nordisk has seen its position in the Chinese diabetes market whittled away in the last couple of years, but it says new products will keep it on top.
Dr. Reddy's will sell three of Amgen's already-approved drugs in India, extending an earlier deal involving three late-stage pipeline candidates.
Japan's Otsuka is hoping that smart packaging could help one of its main pharma products maintain a hold in the marketplace.
Sun Pharma's takeover of Ranbaxy is not sitting well with some of the latter's sales reps. Hundreds are threatening an all-out strike later this…
Hepatitis C is a big problem in China, and drugmakers are still waiting on approval for their next-gen treatments. Now, regulators are promising action--and…
Vietnam has been one of the fastest-growing economies in Asia in recent years, and Sanofi has just cut a deal to give it a stronger position in the market.
Pharma companies are risking the wrath of India's drugs regulator by ignoring a demand for clinical trials of combination drugs.
Government warns drugmakers could leave the UK if the country's separation from the EU drags on and is kept under wraps.
With Mitsubishi Tanabe deal, Sun Pharma takes a basket of new meds into Japan, a market where Indian drugmakers are under-represented.